The realm of vitamin K dependent proteins: Shifting from coagulation toward calcification

Molecular Nutrition and Food Research

Volumn 58, Issue 8, 2014, Pages 1620-1635

  Willems, Brecht A G ^a,b   Vermeer, Cees ^b   Reutelingsperger, Chris P M ^a   Schurgers, Leon J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Gla rich protein; Matrix Gla protein; Osteocalcin; Vascular calcification; Vitamin K

Indexed keywords

ANTICOAGULANT AGENT; VITAMIN K GROUP;

ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; BLOOD CLOTTING; BONE MINERALIZATION; CALCINOSIS; DRUG EFFECTS; HUMAN; MEDICAL RESEARCH; METABOLISM; PATHOPHYSIOLOGY; TRENDS; VITAMIN K DEFICIENCY;

ANIMALS; ANTICOAGULANTS; BIOMEDICAL RESEARCH; BLOOD COAGULATION; CALCIFICATION, PHYSIOLOGIC; CALCINOSIS; HUMANS; MODELS, BIOLOGICAL; VITAMIN K; VITAMIN K DEFICIENCY;

EID: 84905385001     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300743     Document Type: Article

References (194)

1. Stenflo, J., Fernlund, P., Egan, W., Roepstorff, P., Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc. Natl. Acad. Sci. USA 1974, 71, 2730-2733.
2. Nelsestuen, G. L., Suttie, J. W., Mode of action of vitamin K. Calcium binding properties of bovine prothrombin. Biochemistry 1972, 11, 4961-4964.
3. 2+ on the structure of vitamin K-dependent coagulation factors. Haemostasis 1996, 26(Suppl 1), 45-53.
4. Ellison, E. H., Castellino, F. J., Adsorption of vitamin K-dependent blood coagulation proteins to spread phospholipid monolayers as determined from combined measurements of the surface pressure and surface protein concentration. Biochemistry 1998, 37, 7997-8003.
5. Hauschka, P. V., Lian, J. B., Gallop, P. M., Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc. Natl. Acad. Sci. USA 1975, 72, 3925-3929.
6. Price, P. A., Urist, M. R., Otawara, Y., Matrix Gla protein, a new γ-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem. Biophys. Res. Commun. 1983, 117, 765-771.
7. Surmann-Schmitt, C., Dietz, U., Kireva, T., Adam, N. et al., Ucma, a novel secreted cartilage-specific protein with implications in osteogenesis. J. Biol. Chem. 2008, 283, 7082-7093.
8. Tagariello, A., Luther, J., Streiter, M., Didt-Koziel, L. et al., Ucma-a novel secreted factor represents a highly specific marker for distal chondrocytes. Matrix Biol. 2008, 27, 3-11.
9. Viegas, C. S., Simes, D. C., Laize, V., Williamson, M. K. et al., Gla-rich protein (GRP), a new vitamin K-dependent protein identified from sturgeon cartilage and highly conserved in vertebrates. J. Biol. Chem. 2008, 283, 36655-36664.
10. Dam, H., Schonheyder, F., The occurrence and chemical nature of vitamin K. Biochem. J. 1936, 30, 897-901.
11. Martius, C., Esser, H. O., The constitution of vitamin K formed from methylnaphthoquinone in animal body. Biochem Z. 1958, 331, 1-9.
12. Shearer, M. J., Newman, P., Metabolism and cell biology of vitamin K. Thromb. Haemost. 2008, 100, 530-547.
13. Conly, J. M., Stein, K., Quantitative and qualitative measurements of K vitamins in human intestinal contents. Am. J. Gastroenterol. 1992, 87, 311-316.
14. Morishita, T., Tamura, N., Makino, T., Kudo, S., Production of menaquinones by lactic acid bacteria. J. Dairy Sci. 1999, 82, 1897-1903.
15. Suttie, J. W., The importance of menaquinones in human nutrition. Annu. Rev. Nutr. 1995, 15, 399-417.
16. Thane, C. W., Wang, L. Y., Coward, W. A., Plasma phylloquinone (vitamin K1) concentration and its relationship to intake in British adults aged 19-64 years. Br. J. Nutr. 2006, 96, 1116-1124.
17. Rishavy, M. A., Hallgren, K. W., Wilson, L. A., Usubalieva, A. et al., The vitamin K oxidoreductase is a multimer that efficiently reduces vitamin K epoxide to hydroquinone to allow vitamin K-dependent protein carboxylation. J. Biol. Chem. 2013, 288, 31556-31566.
18. Link, K. P., The discovery of dicumarol and its sequels. Circulation 1959, 19, 97-107.
19. Chatrou, M. L., Winckers, K., Hackeng, T. M., Reutelingsperger, C. P. et al., Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists. Blood Rev. 2012, 26, 155-166.
20. Schurgers, L. J., Joosen, I. A., Laufer, E. M., Chatrou, M. L. et al., Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype. PLoS One 2012, 7, e43229.
21. McCabe, K. M., Booth, S. L., Fu, X., Shobeiri, N. et al., Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int. 2013, 83, 835-844.
22. Kruger, T., Oelenberg, S., Kaesler, N., Schurgers, L. J. et al., Warfarin induces cardiovascular damage in mice. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 2618-2624.
23. Price, P. A., Faus, S. A., Williamson, M. K., Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 1400-1407.
24. Kawasaki, K., Buchanan, A. V., Weiss, K. M., Biomineralization in humans: making the hard choices in life. Annu. Rev. Genet. 2009, 43, 119-142.
25. Leening, M. J., Elias-Smale, S. E., Kavousi, M., Felix, J. F. et al., Coronary calcification and the risk of heart failure in the elderly: the Rotterdam Study. JACC Cardiovasc. Imaging 2012, 5, 874-880.
26. Rifkin, D. E., Ix, J. H., Wassel, C. L., Criqui, M. H. et al., Renal artery calcification and mortality among clinically asymptomatic adults. J. Am. Coll. Cardiol. 2012, 60, 1079-1085.
27. Akkus, O., Adar, F., Schaffler, M. B., Age-related changes in physicochemical properties of mineral crystals are related to impaired mechanical function of cortical bone. Bone 2004, 34, 443-453.
28. Hessle, L., Johnson, K. A., Anderson, H. C., Narisawa, S. et al., Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc. Natl. Acad. Sci. USA 2002, 99, 9445-9449.
29. Knothe Tate, M. L., Adamson, J. R., Tami, A. E., Bauer, T. W., The osteocyte. Int. J. Biochem. Cell Biol. 2004, 36, 1-8.
30. Harada, S., Rodan, G. A., Control of osteoblast function and regulation of bone mass. Nature 2003, 423, 349-355.
31. Teitelbaum, S. L., Bone resorption by osteoclasts. Science 2000, 289, 1504-1508.
32. Boyle, W. J., Simonet, W. S., Lacey, D. L., Osteoclast differentiation and activation. Nature 2003, 423, 337-342.
33. Kennedy, O. D., Schaffler, M. B., The roles of osteocyte signaling in bone. J. Am. Acad. Orthop. Surg. 2012, 20, 670-671.
34. Murshed, M., McKee, M. D., Molecular determinants of extracellular matrix mineralization in bone and blood vessels. Curr. Opin. Nephrol. Hypertens. 2010, 19, 359-365.
35. Studer, D., Millan, C., Ozturk, E., Maniura-Weber, K. et al., Molecular and biophysical mechanisms regulating hypertrophic differentiation in chondrocytes and mesenchymal stem cells. Eur. Cell Mater. 2012, 24, 118-135.
36. Mackie, E. J., Tatarczuch, L., Mirams, M., The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J. Endocrinol. 2011, 211, 109-121.
37. Raisz, L. G., Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 2005, 115, 3318-3325.
38. Tolar, J., Teitelbaum, S. L., Orchard, P. J., Osteopetrosis N. Engl. J. Med. 2004, 351, 2839-2849.
39. Adele, B., Bone mineral crystal size. Osteoporos Int. 2003, 14(Suppl 5), S16-S20; discussion S20-11.
40. Aubin, J., Liu, F., Malaval, L., Gupta, A., Osteoblast and chondroblast differentiation. Bone 1995, 17, S77-S83.
41. Lian, J. B., McKee, M. D., Todd, A. M., Gerstenfeld, L. C., Induction of bone-related proteins, osteocalcin and osteopontin, and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro. J. Cell. Biochem. 1993, 52, 206-219.
42. Hoang, Q. Q., Sicheri, F., Howard, A. J., Yang, D. S., Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 2003, 425, 977-980.
43. Katagiri, T., Takahashi, N., Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis. 2002, 8, 147-159.
44. Ducy, P., Desbois, C., Boyce, B., Pinero, G. et al., Increased bone formation in osteocalcin-deficient mice. Nature 1996, 382, 448-452.
45. Boskey, A. L., Gadaleta, S., Gundberg, C., Doty, S. B. et al., Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998, 23, 187-196.
46. Hunter, G., Hauschka, P., Poole, A., Rosenberg, L. et al., Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem. J. 1996, 317, 59-64.
47. Knepper-Nicolai, B., Reinstorf, A., Hofinger, I., Flade, K. et al., Influence of osteocalcin and collagen I on the mechanical and biological properties of Biocement D. Biomol. Eng. 2002, 19, 227-231.
48. Rammelt, S., Neumann, M., Hanisch, U., Reinstorf, A. et al., Osteocalcin enhances bone remodeling around hydroxyapatite/collagen composites. J. Biomed. Mater. Res. Part A 2005, 73, 284-294.
49. Bodine, P. V., Komm, B. S., Evidence that conditionally immortalized human osteoblasts express an osteocalcin receptor. Bone 1999, 25, 535-543.
50. Pelled, G., Gazit, D., Imaging using osteocalcin-luciferase. J Musculoskelet. Neuronal. Interact. 2004, 4, 362-363.
51. Mundy, G. R., Poser, J. W., Chemotactic activity of the gamma-carboxyglutamic acid containing protein in bone. Calcif. Tissue Int. 1983, 35, 164-168.
52. DeFranco, D. J., Glowacki, J., Cox, K. A., Lian, J. B., Normal bone particles are preferentially resorbed in the presence of osteocalcin-deficient bone particles in vivo. Calcif. Tissue Int. 1991, 49, 43-50.
53. Chenu, C., Colucci, S., Grano, M., Zigrino, P. et al., Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J. Cell Biol. 1994, 127, 1149-1158.
54. Liggett, W. H., Jr., Lian, J. B., Greenberger, J. S., Glowacki, J., Osteocalcin promotes differentiation of osteoclast progenitors from murine long-term bone marrow cultures. J. Cell. Biochem. 1994, 55, 190-199.
55. Ishida, M., Amano, S., Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation. J. Bone Miner. Metab. 2004, 22, 415-429.
56. Lian, J. B., Gundberg, C. M., Osteocalcin. Biochemical considerations and clinical applications. Clin. Orthop. Relat. Res. 1988, 226, 267-291.
57. Kruger, M. C., Booth, C. L., Coad, J., Schollum, L. M. et al., Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women. Nutrition 2006, 22, 1120-1128.
58. Vermeer, C., Gijsbers, B. L., Craciun, A. M., Groenen-van Dooren, M. M. et al., Effects of vitamin K on bone mass and bone metabolism. J. Nutr. 1996, 126(4 Suppl), 1187S-1191S.
59. Booth, S. L., Dallal, G., Shea, M. K., Gundberg, C. et al., Effect of vitamin K supplementation on bone loss in elderly men and women. J. Clin. Endocrinol. Metab. 2008, 93, 1217-1223.
60. Cheung, A. M., Tile, L., Lee, Y., Tomlinson, G. et al., Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med. 2008, 5, e196.
61. Binkley, N., Harke, J., Krueger, D., Engelke, J. et al., Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. J. Bone Miner. Res. 2009, 24, 983-991.
62. Lee, N. K., Sowa, H., Hinoi, E., Ferron, M. et al., Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130, 456-469.
63. Oury, F., Sumara, G., Sumara, O., Ferron, M. et al., Endocrine regulation of male fertility by the skeleton. Cell 2011, 144, 796-809.
64. Karsenty, G., Ferron, M., The contribution of bone to whole-organism physiology. Nature 2012, 481, 314-320.
65. Hale, J. E., Fraser, J. D., Price, P. A., The identification of matrix Gla protein in cartilage. J. Biol. Chem. 1988, 263, 5820-5824.
66. Luo, G., D'Souza, R., Hogue, D., Karsenty, G., The matrix Gla protein gene is a marker of the chondrogenesis cell lineage during mouse development. J. Bone Miner. Res. 1995, 10, 325-334.
67. Otawara, Y., Price, P. A., Developmental appearance of matrix Gla protein during calcification in the rat. J. Biol. Chem. 1986, 261, 10828-10832.
68. Loeser, R., Carlson, C. S., Tulli, H., Jerome, W. G. et al., Articular-cartilage matrix gamma-carboxyglutamic acid-containing protein. Characterization and immunolocalization. Biochem. J. 1992, 282(Pt 1), 1-6.
69. Luo, G., Ducy, P., McKee, M. D., Pinero, G. J. et al., Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature 1997, 386, 78-81.
70. Newman, B., Gigout, L. I., Sudre, L., Grant, M. E. et al., Coordinated expression of matrix Gla protein is required during endochondral ossification for chondrocyte survival. J. Cell Biol. 2001, 154, 659-666.
71. Yagami, K., Suh, J. Y., Enomoto-Iwamoto, M., Koyama, E. et al., Matrix Gla protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J. Cell Biol. 1999, 147, 1097-1108.
72. Roy, M. E., Nishimoto, S. K., Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: calcium enhances binding affinity but phosphate and magnesium decrease affinity. Bone 2002, 31, 296-302.
73. Munroe, P. B., Olgunturk, R. O., Fryns, J. P., Van Maldergem, L. et al., Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat. Genet. 1999, 21, 142-144.
74. Kaipatur, N. R., Murshed, M., McKee, M. D., Matrix Gla protein inhibition of tooth mineralization. J. Dent. Res. 2008, 87, 839-844.
75. Murshed, M., Schinke, T., McKee, M. D., Karsenty, G., Extracellular matrix mineralization is regulated locally; different roles of two Gla-containing proteins. J. Cell Biol. 2004, 165, 625-630.
76. Wallin, R., Schurgers, L. J., Loeser, R. F., Biosynthesis of the vitamin K-dependent matrix Gla protein (MGP) in chondrocytes: a fetuin-MGP protein complex is assembled in vesicles shed from normal but not from osteoarthritic chondrocytes. Osteoarthritis Cartilage 2010, 18, 1096-1103.
77. Wallin, R., Cain, D., Hutson, S. M., Sane, D. C. et al., Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2). Thromb. Haemost. 2000, 84, 1039-1044.
78. Zebboudj, A. F., Imura, M., Bostrom, K., Matrix Gla protein, a regulatory protein for bone morphogenetic protein-2. J. Biol. Chem. 2002, 277, 4388-4394.
79. Rosen, V., BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev. 2009, 20, 475-480.
80. Okubo, Y., Bessho, K., Fujimura, K., Konishi, Y. et al., Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. Int. J. Oral Maxillofac. Surg. 2000, 29, 62-66.
81. Zebboudj, A. F., Shin, V., Bostrom, K., Matrix Gla protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J. Cell. Biochem. 2003, 90, 756-765.
82. Neacsu, C. D., Grosch, M., Tejada, M., Winterpacht, A. et al., Ucmaa (Grp-2) is required for zebrafish skeletal development. Evidence for a functional role of its glutamate gamma-carboxylation. Matrix Biol. 2011, 30, 369-378.
83. Eitzinger, N., Surmann-Schmitt, C., Bosl, M., Schett, G. et al., Ucma is not necessary for normal development of the mouse skeleton. Bone 2012, 50, 670-680.
84. Giachelli, C. M., Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthod. Craniofac. Res. 2005, 8, 229-231.
85. Murphy, W. A., Jr., Nedden Dz, D., Gostner, P., Knapp, R. et al., The iceman: discovery and imaging. Radiology 2003, 226, 614-629.
86. Thompson, R. C., Allam, A. H., Lombardi, G. P., Wann, L. S. et al., Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations. Lancet 2013, 381, 1211-1222.
87. Virchow, R. L. K., Cellular Pathology, John Churchill, London 1860.
88. Speer, M. Y., Giachelli, C. M., Regulation of cardiovascular calcification. Cardiovasc. Pathol. 2004, 13, 63-70.
89. van Varik, B. J., Rennenberg, R. J., Reutelingsperger, C. P., Kroon, A. A. et al., Mechanisms of arterial remodeling: lessons from genetic diseases. Front. Genet. 2012, 3, 290.
90. Demer, L. L., Tintut, Y., Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008, 117, 2938-2948.
91. Greenland, P., LaBree, L., Azen, S. P., Doherty, T. M. et al., Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. J. Am. Med. Assoc. 2004, 291, 210-215.
92. LaMonte, M. J., FitzGerald, S. J., Church, T. S., Barlow, C. E. et al., Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women. Am. J. Epidemiol. 2005, 162, 421-429.
93. Sage, A. P., Tintut, Y., Demer, L. L., Regulatory mechanisms in vascular calcification. Nat. Rev. Cardiol. 2010, 7, 528-536.
94. Strong, J. p., Malcom, G. T., McMahan, C. A., Tracy, R. E. et al., Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the pathobiological determinants of atherosclerosis in youth study. J. Am. Med. Assoc. 1999, 281, 727-735.
95. Achenbach, S., Ropers, D., Pohle, K., Leber, A. et al., Influence of lipid-lowering therapy on the progression of coronary artery calcification a prospective evaluation. Circulation 2002, 106, 1077-1082.
96. New, S. E., Aikawa, E., Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ. Res. 2011, 108, 1381-1391.
97. Libby, P., Inflammation in atherosclerosis. Nature 2002, 420, 868-874.
98. Nadra, I., Mason, J. C., Philippidis, P., Florey, O. et al., Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ. Res. 2005, 96, 1248-1256.
99. Roijers, R. B., Debernardi, N., Cleutjens, J. P., Schurgers, L. J. et al., Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries. Am. J. Pathol. 2011, 178, 2879-2887.
100. Huang, H., Virmani, R., Younis, H., Burke, A. P. et al., The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation 2001, 103, 1051-1056.
101. Vengrenyuk, Y., Carlier, S., Xanthos, S., Cardoso, L. et al., A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proc. Natl. Acad. Sci. USA 2006, 103, 14678-14683.
102. Maldonado, N., Kelly-Arnold, A., Vengrenyuk, Y., Laudier, D. et al., A mechanistic analysis of the role of microcalcifications in atherosclerotic plaque stability: potential implications for plaque rupture. Am. J. Physiol. Heart Circ. Physiol. 2012, 303, H619-H628.
103. Kelly-Arnold, A., Maldonado, N., Laudier, D., Aikawa, E. et al., Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries. Proc. Natl. Acad. Sci. USA 2013, 110, 10741-10746.
104. Mizobuchi, M., Towler, D., Slatopolsky, E., Vascular calcification: the killer of patients with chronic kidney disease. J. Am. Soc. Nephrol. 2009, 20, 1453-1464.
105. Edmonds, M., Medial arterial calcification and diabetes mellitus. Z. Kardiol. 2000, 89, S101-S104.
106. Garimella, P. S., Sarnak, M. J., Cardiovascular disease in CKD in 2012: moving forward, slowly but surely. Nat. Rev. Nephrol. 2013, 9, 69-70.
107. Jahnen-Dechent, W., Schafer, C., Heiss, A., Grotzinger, J., Systemic inhibition of spontaneous calcification by the serum protein alpha 2-HS glycoprotein/fetuin. Z. Kardiol. 2001, 90(Suppl 3), 47-56.
108. Jahnen-Dechent, W., Heiss, A., Schafer, C., Ketteler, M., Fetuin-A regulation of calcified matrix metabolism. Circ. Res. 2011, 108, 1494-1509.
109. Schurgers, L. J., Uitto, J., Reutelingsperger, C. P., Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol. Med. 2013, 19, 217-226.
110. Price, P. A., Lim, J. E., The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J. Biol. Chem. 2003, 278, 22144-22152.
111. Merx, M. W., Schafer, C., Westenfeld, R., Brandenburg, V. et al., Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. J. Am. Soc. Nephrol. 2005, 16, 3357-3364.
112. Schurgers, L. J., Dissel, P. E. P., Spronk, H. M. H., Soute, B. A. M. et al., Role of vitamin K and vitamin K-dependent proteins in vascular calcification. Z. Kardiol. 2001, 90, 57-63.
113. Price, P. A., Chan, W. S., Jolson, D. M., Williamson, M. K., The elastic lamellae of devitalized arteries calcify when incubated in serum evidence for a serum calcification factor. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1079-1085.
114. Marulanda, J., Gao, C., Roman, H., Henderson, J. E. et al., Prevention of arterial calcification corrects the low bone mass phenotype in MGP-deficient mice. Bone 2013, 57, 499-508.
115. Price, P. A., Thomas, G. R., Pardini, A. W., Figueira, W. F. et al., Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J. Biol. Chem. 2002, 277, 3926-3934.
116. Matsui, I., Hamano, T., Mikami, S., Fujii, N. et al., Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int. 2009, 75, 915-928.
117. Price, P. A., Caputo, J. M., Williamson, M. K., Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. J. Bone Miner. Res. 2002, 17, 1171-1179.
118. Price, P. A., Nguyen, T. M., Williamson, M. K., Biochemical characterization of the serum fetuin-mineral complex. J. Biol. Chem. 2003, 278, 22153-22160.
119. Kolodgie, F. D., Narula, J., Burke, A. P., Haider, N. et al., Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am. J. Pathol. 2000, 157, 1259-1268.
120. Proudfoot, D., Skepper, J. N., Hegyi, L., Bennett, M. R. et al., Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ. Res. 2000, 87, 1055-1062.
121. Reynolds, J. L., Joannides, A. J., Skepper, J. N., McNair, R. et al., Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J. Am. Soc. Nephrol. 2004, 15, 2857-2867.
122. Shroff, R. C., McNair, R., Figg, N., Skepper, J. N. et al., Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008, 118, 1748-1757.
123. Anderson, H. C., Electron microscopic studies of induced cartilage development and calcification. J. Cell Biol. 1967, 35, 81-101.
124. Tanimura, A., McGregor, D. H., Anderson, H. C., Matrix vesicles in atherosclerotic calcification. Proc. Soc. Exp. Biol. Med. 1983, 172, 173-177.
125. Rensen, S., Doevendans, P., Van Eys, G., Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth. Heart J. 2007, 15, 100-108.
126. Alexander, M. R., Owens, G. K., Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu. Rev. Physiol. 2012, 74, 13-40.
127. Leroux-Berger, M., Queguiner, I., Maciel, T. T., Ho, A. et al., Pathologic calcification of adult vascular smooth muscle cells differs on their crest or mesodermal embryonic origin. J. Bone Miner. Res. 2011, 26, 1543-1553.
128. Khavandgar, Z., Roman, H., Li, J., Lee, S. et al., Elastin haploinsufficiency impedes the progression of arterial calcification in MGP-deficient mice. J. Bone Miner. Res. 2013, 29, 327-337.
129. Shanahan, C. M., Crouthamel, M. H., Kapustin, A., Giachelli, C. M., Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ. Res. 2011, 109, 697-711.
130. Tintut, Y., Parhami, F., Bostrom, K., Jackson, S. M. et al., cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J. Biol. Chem. 1998, 273, 7547-7553.
131. Byon, C. H., Javed, A., Dai, Q., Kappes, J. C. et al., Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J. Biol. Chem. 2008, 283, 15319-15327.
132. Speer, M. Y., Li, X., Hiremath, P. G., Giachelli, C. M., Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J. Cell. Biochem. 2010, 110, 935-947.
133. Severson, A. R., Ingram, R. T., Fitzpatrick, L. A., Matrix proteins associated with bone calcification are present in human vascular smooth muscle cells grown in vitro. In Vitro Cell. Dev. Biol. Anim. 1995, 31, 853-857.
134. Dhore, C. R., Cleutjens, J. P., Lutgens, E., Cleutjens, K. B. et al., Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1998-2003.
135. Trion, A., van der Laarse, A., Vascular smooth muscle cells and calcification in atherosclerosis. Am. Heart J. 2004, 147, 808-814.
136. Foresta, C., Strapazzon, G., De Toni, L., Fabris, F. et al., Platelets express and release osteocalcin and co-localize in human calcified atherosclerotic plaques. J. Thromb. Haemost. 2013, 11, 357-365.
137. Price, P. A., Roublick, A. M., Williamson, M. K., Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int. 2006, 70, 1577-1583.
138. Okura, T., Kurata, M., Enomoto, D., Jotoku, M. et al., Undercarboxylated osteocalcin is a biomarker of carotid calcification in patients with essential hypertension. Kidney Blood Press. Res. 2010, 33, 66-71.
139. Idelevich, A., Rais, Y., Monsonego-Ornan, E., Bone Gla protein increases HIF-1alpha-dependent glucose metabolism and induces cartilage and vascular calcification. Arterioscler. Thromb. Vasc. Biol. 2011, 31, e55-71.
140. Flammer, A. J., Gossl, M., Widmer, R. J., Reriani, M. et al., Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis. Eur. Heart J. 2012, 33, 2963-2969.
141. Balica, M., Bostrom, K., Shin, V., Tillisch, K. et al., Calcifying subpopulation of bovine aortic smooth muscle cells is responsive to 17 beta-estradiol. Circulation 1997, 95, 1954-1960.
142. Kapustin, A. N., Shanahan, C. M., Osteocalcin a novel vascular metabolic and osteoinductive factor? Arterioscler. Thromb. Vasc. Biol. 2011, 31, 2169-2171.
143. Fadini, G. P., Albiero, M., Menegazzo, L., Boscaro, E. et al., Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ. Res. 2011, 108, 1112-1121.
144. Pal, S. N., Rush, C., Parr, A., Van Campenhout, A. et al., Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. Atherosclerosis 2010, 210, 88-93.
145. Fadini, G. P., Albiero, M., Menegazzo, L., Boscaro, E. et al., Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. Exp. Diabetes Res. 2012, 2012, 921685.
146. Shanahan, C. M., Weissberg, P. L., Metcalfe, J. C., Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ. Res. 1993, 73, 193-204.
147. Shanahan, C. M., Cary, N. R., Metcalfe, J. C., Weissberg, P. L., High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J. Clin. Invest. 1994, 93, 2393-2402.
148. Proudfoot, D., Skepper, J. N., Shanahan, C. M., Weissberg, P. L., Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 379-388.
149. Mendoza, F. J., Martinez-Moreno, J., Almaden, Y., Rodriguez-Ortiz, M. E. et al., Effect of calcium and the calcimimetic AMG 641 on matrix-Gla protein in vascular smooth muscle cells. Calcif. Tissue Int. 2011, 88, 169-178.
150. Farzaneh-Far, A., Proudfoot, D., Weissberg, P. L., Shanahan, C. M., Matrix Gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor. Biochem. Biophys. Res. Commun. 2000, 277, 736-740.
151. Schurgers, L. J., Teunissen, K. J., Knapen, M. H., Kwaijtaal, M. et al., Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 1629-1633.
152. Cranenburg, E. C., Vermeer, C., Koos, R., Boumans, M. L. et al., The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J. Vasc. Res. 2008, 45, 427-436.
153. Dalmeijer, G. W., van der Schouw, Y. T., Vermeer, C., Magdeleyns, E. J. et al., Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women. J. Nutr. Biochem. 2013, 24, 624-628.
154. Schurgers, L. J., Spronk, H. M., Skepper, J. N., Hackeng, T. M. et al., Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J. Thromb. Haemost. 2007, 5, 2503-2511.
155. O'Young, J., Liao, Y., Xiao, Y., Jalkanen, J. et al., Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. J. Am. Chem. Soc. 2011, 133, 18406-18412.
156. Rennenberg, R. J., van Varik, B. J., Schurgers, L. J., Hamulyak, K. et al., Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood 2010, 115, 5121-5123.
157. Weijs, B., Blaauw, Y., Rennenberg, R. J., Schurgers, L. J. et al., Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur. Heart J. 2011, 32, 2555-2562.
158. Villines, T. C., O'Malley, P. G., Feuerstein, I. M., Thomas, S. et al., Does prolonged warfarin exposure potentiate coronary calcification in humans? Results of the warfarin and coronary calcification study. Calcif. Tissue Int. 2009, 85, 494-500.
159. Palaniswamy, C., Aronow, W. S., Sekhri, A., Adapa, S. et al., Warfarin use and prevalence of coronary artery calcification assessed by multislice computed tomography. Am. J. Ther. 2012. DOI:10.1097/MJT.0b013e318249a1c6.
160. El-Maadawy, S., Kaartinen, M. T., Schinke, T., Murshed, M. et al., Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect. Tissue Res. 2003, 44(Suppl 1), 272-278.
161. Yao, Y., Bennett, B. J., Wang, X., Rosenfeld, M. E. et al., Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circ. Res. 2010, 107, 485-494.
162. Li, X., Yang, H. Y., Giachelli, C. M., BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 2008, 199, 271-277.
163. Yao, Y., Zebboudj, A. F., Shao, E., Perez, M. et al., Regulation of bone morphogenetic protein-4 by matrix GLA protein in vascular endothelial cells involves activin-like kinase receptor 1. J. Biol. Chem. 2006, 281, 33921-33930.
164. Wallin, R., Schurgers, L., Wajih, N., Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification. Thromb. Res. 2008, 122, 411-417.
165. Price, P. A., Faus, S. A., Williamson, M. K., Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 317-327.
166. Tyson, K. L., Reynolds, J. L., McNair, R., Zhang, Q. et al., Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 489-494.
167. Tamura, K., Suzuki, Y., Matsushita, M., Fujii, H. et al., Prevention of aortic calcification by etidronate in the renal failure rat model. Eur. J. Pharmacol. 2007, 558, 159-166.
168. Viegas, C. S., Cavaco, S., Neves, P. L., Ferreira, A. et al., Gla-rich protein is a novel vitamin K-dependent protein present in serum that accumulates at sites of pathological calcifications. Am. J. Pathol. 2009, 175, 2288-2298.
169. Le Jeune, M., Tomavo, N., Tian, T. V., Flourens, A. et al., Identification of four alternatively spliced transcripts of the Ucma/GRP gene, encoding a new Gla-containing protein. Exp. Cell Res. 2010, 316, 203-215.
170. Shearer, M. J., Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Rev. 2009, 23, 49-59.
171. Krueger, T., Westenfeld, R., Ketteler, M., Schurgers, L. J. et al., Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? Kidney Int. 2009, 76, 18-22.
172. Cranenburg, E. C., Schurgers, L. J., Uiterwijk, H. H., Beulens, J. W. et al., Vitamin K intake and status are low in hemodialysis patients. Kidney Int. 2012, 82, 605-610.
173. Malyszko, J., Wolczynski, S., Skrzydlewska, E., Malyszko, J. S. et al., Vitamin K status in relation to bone metabolism in patients with renal failure. Am. J. Nephrol. 2002, 22, 504-508.
174. Pilkey, R. M., Morton, A. R., Boffa, M. B., Noordhof, C. et al., Subclinical vitamin K deficiency in hemodialysis patients. Am. J. Kidney Dis. 2007, 49, 432-439.
175. Schlieper, G., Westenfeld, R., Kruger, T., Cranenburg, E. C. et al., Circulating nonphosphorylated carboxylated matrix Gla protein predicts survival in ESRD. J. Am. Soc. Nephrol. 2011, 22, 387-395.
176. Goodman, W. G., Vascular calcification in chronic renal failure. Lancet 2001, 358, 1115-1116.
177. Gage, B. F., Birman-Deych, E., Radford, M. J., Nilasena, D. S. et al., Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch. Intern. Med. 2006, 166, 241-246.
178. Lafforgue, P., Daver, L., Monties, J. R., Chagnaud, C. et al., Bone mineral density in patients given oral vitamin K antagonists. Rev. Rhum. Engl. Ed. 1997, 64, 249-254.
179. Mamdani, M., Upshur, R. E., Anderson, G., Bartle, B. R. et al., Warfarin therapy and risk of hip fracture among elderly patients. Pharmacotherapy 2003, 23, 1-4.
180. Pilon, D., Castilloux, A. M., Dorais, M., LeLorier, J., Oral anticoagulants and the risk of osteoporotic fractures among elderly. Pharmacoepidemiol. Drug Saf. 2004, 13, 289-294.
181. Stenova, E., Steno, B., Killinger, Z., Baqi, L. et al., Effect of long-term oral anticoagulant therapy on bone mineral density and bone turnover markers: a prospective 12 month study. Bratisl. Lek. Listy. 2011, 112, 71-76.
182. Shearer, M. J., Rahim, S., Barkhan, P., Stimmler, L., Plasma vitamin K1 in mothers and their newborn babies. Lancet 1982, 2, 460-463.
183. Clarke, P., Mitchell, S. J., Sundaram, S., Sharma, V. et al., Vitamin K status of preterm infants with a prolonged prothrombin time. Acta Paediatr. 2005, 94, 1822-1824.
184. Harrington, D. J., Clarke, P., Card, D. J., Mitchell, S. J. et al., Urinary excretion of vitamin K metabolites in term and preterm infants: relationship to vitamin K status and prophylaxis. Pediatr. Res. 2010, 68, 508-512.
185. Fusaro, M., Noale, M., Viola, V., Galli, F. et al., Vitamin K, vertebral fractures, vascular calcifications, and mortality: vitamin K Italian (VIKI) dialysis study. J. Bone Miner. Res. 2012, 27, 2271-2278.
186. Knapen, M. H., Drummen, N. E., Smit, E., Vermeer, C. et al., Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos. Int. 2013, 24, 2499-2507.
187. Fu, X., Moreines, J., Booth, S. L., Vitamin K supplementation does not prevent bone loss in ovariectomized Norway rats. Nutr. Metab. 2012, 9, 12.
188. Martini, L. A., Booth, S. L., Saltzman, E., do Rosario Dias de Oliveira Latorre, M. et al., Dietary phylloquinone depletion and repletion in postmenopausal women: effects on bone and mineral metabolism. Osteoporos. Int. 2006, 17, 929-935.
189. Knapen, M. H., Schurgers, L. J., Vermeer, C., Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos. Int. 2007, 18, 963-972.
190. Shea, M. K., Booth, S. L., Miller, M. E., Burke, G. L. et al., Association between circulating vitamin K1 and coronary calcium progression in community-dwelling adults: the Multi-Ethnic Study of Atherosclerosis. Am. J. Clin. Nutr. 2013, 98, 197-208.
191. Braam, L. A., Hoeks, A. P., Brouns, F., Hamulyak, K. et al., Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb. Haemost. 2004, 91, 373-380.
192. Shea, M. K., O'Donnell, C. J., Hoffmann, U., Dallal, G. E. et al., Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am. J. Clin. Nutr. 2009, 89, 1799-1807.
193. Westenfeld, R., Krueger, T., Schlieper, G., Cranenburg, E. C. M. et al., Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am. J. Kidney Dis. 2012, 59, 186-195.
194. Shea, M. K., Holden, R. M., Vitamin K status and vascular calcification: evidence from observational and clinical studies. Adv. Nutr. 2012, 3, 158-165.